Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-18-000075
Filing Date
2018-03-08
Accepted
2018-03-08 16:23:14
Documents
110
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K body10k.htm 10-K 1378974
2 BYLAWS exh3-2.htm EX-3.2 175399
3 OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDI exh10-41.htm EX-10.41 6152
4 OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDI exh10-42.htm EX-10.42 6151
5 WAIVER, AMENDMENT AND CONSENT AGREEMENT, DATED NOVEMBER 2, 2017, AMONG PERNIX TH exh10-43.htm EX-10.43 17848
6 SUBSIDIARIES exh21-1.htm EX-21.1 6506
7 CONSENT exh23-1.htm EX-23.1 1299
8 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 5088
9 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 4835
10 906 CERTIFICATE exh32-1.htm EX-32.1 3258
11 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-18-000075.txt   6665194

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT ptx-20171231.xml EX-101.INS 1156415
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptx-20171231.xsd EX-101.SCH 72414
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptx-20171231_cal.xml EX-101.CAL 117090
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptx-20171231_def.xml EX-101.DEF 150912
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptx-20171231_lab.xml EX-101.LAB 554767
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptx-20171231_pre.xml EX-101.PRE 394931
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14494 | Film No.: 18676723
SIC: 2834 Pharmaceutical Preparations